Cite
Rusckowski M, Wang Y, Blankenberg FG, et al. Targeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy. EJNMMI Res. 2016;6(1):4doi: 10.1186/s13550-016-0163-1.
Rusckowski, M., Wang, Y., Blankenberg, F. G., Levashova, Z., Backer, M. V., & Backer, J. M. (2016). Targeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy. EJNMMI research, 6(1), 4. https://doi.org/10.1186/s13550-016-0163-1
Rusckowski, Mary, et al. "Targeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy." EJNMMI research vol. 6,1 (2016): 4. doi: https://doi.org/10.1186/s13550-016-0163-1
Rusckowski M, Wang Y, Blankenberg FG, Levashova Z, Backer MV, Backer JM. Targeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy. EJNMMI Res. 2016 Dec;6(1):4. doi: 10.1186/s13550-016-0163-1. Epub 2016 Jan 16. PMID: 26780081; PMCID: PMC4715132.
Copy
Download .nbib